OHMEDA MONITORING SYSTEM
JOSE RIZAL UNIVERSITY Group 4 Erol Pepino Arlene Zaratan ueenie !i
E"e#uti$e Su%%ar&
O'%e(a Monitorin) S&*te%* +a* a ,u*ine** unit o- T'e !O. Group/ a %ultinational 0r% 'ea(1uartere( in 2in(le*'a%/ En)lan(3 T'e )roup 'a( an international port-olio (e*#ri,e( a( +orl(5#o%petiti$e6 ,u*ine** prin#ipall& in(u*trial )a*e*/ 'ealt' #are pro(u#t* an( *er$i#e*/ an( 'i)'5$a#uu% te#'nolo)&3 !O. Healt' .are pro$i(e( pro(u#t* an( *er$i#e* -or #riti#al #are in 'o*pital an( t'e 'o%e/ t'eir e1uip%ent/ t'erapie* an( p'ar%a#euti#al* +ere u*e( in operatin) roo%*7OR8 ， re#o$er& roo%* （ PA.U8 ， an( inten*i$e #are （ I.U ） an( #ar(ia# #are 7..U8unit* t'rou)'out t'e +orl(3
E"e#uti$e Su%%ar&
O'%e(a Healt' .are 7t'e e1uip%ent an( *&*te%* #o%ponent8 +a* an autono%ou* (i$i*ion o- !O. Healt' .are3
It +a* %a(e up o- 0$e %a9or ,u*ine** unit* / plu* a 0el( operation* unit3 O'%e(a Monitorin) S&*te%* 7'ea(1uartere( in Loui*$ille/ .olora(o8 (e*i)ne( /%anu-a#ture( an( *ol( %onitorin) e1uip%ent -or a nu%,er o- *e)%ent* o- t'e 'ealt' #are in(u*tr&3
T'e 'ealt' #are in(u*tr& +a* one o- t'e lar)e*t an( %o*t rapi(l& )ro+in) *e)%ent* o- t'e +orl( e#ono%&3 Ho*pital* +ere t'e prin#ipal ,u&er* o- O'%e(a pro(u#t*3 Mo(ern %e(i#ine $ie+e( %ea*ure%ent o- arterial ,loo( pre**ure a* e**ential in t'e %onitorin) o- patient*/ ,ot' (urin) an( a-ter *ur)er&3 Tra(itional %onitorin) te#'ni1ue* 'a$e in#lu(e( ,ot' in$a*i$e an( nonin$a*i$e %et'o(*3
E"e#uti$e Su%%ar&
In :;<= O'%e(a a#1uire( an e"#lu*i$e li#en*e -or t'e >inapre* te#'nolo)&3
>a$ora,le te*t re*ult* o- #lini#al *tu(ie* o- >inapre* +ere reporte( in %e(i#al 9ournal* an( +ere +i(el& (i*tri,ute( to t'e %e(i#al pro-e**ion3
VIE2POINT Jo*ep' 23 Pepper/ General Mana)er o- O'%e(a Monitorin)3
TIME .ONTE@T •
In:;; t'ere +a* a 'i)' pro,a,ilit& t'at t'e pro,le% #oul( ,e 0"e( +it' #'an)e* in *o-t+are3
I 5 PRO!LEM STATEMENT :3 T'e te#'nolo)& +a* pur#'a*e(/ ,ut not i%pro$e(3 T'e earlier $er*ion (i( not +orB3 T'e pro(u#t 'a( *o-t+are pro,le%* an( la#B o- lea(er*'ip3
II5 STATEMENT O> THE O!JE.TIVES :3 MaBe *i)ni0#ant in$e*t%ent in RCD an( %arBetin) pertainin) to t'e i%pro$e%ent o- t'e pro(u#t3 3 I%pro$e t'e pro(u#t -eature* in or(er to )et a##urate re*ult -or patient +it' poor ,loo( pre**ure3
III5AREAS O> .ONSIDERATION Stren)t'* 7Internal8 :3 Stron) (i*tri,ution parti#ularl& in OR3 3 Te#'ni#al e"perti*e3 =3 Hea( *tart o$er #o%petitor*3 2eaBne** 7Internal8 43 No *en*e o- purpo*e an( $i*ion a,out t'e pro(u#t3
III5 AREAS O> .ONSIDERATION 7#ont(8 •
Opportunitie* 7E"ternal8
:3 Penetratin) t'e US %arBet3 3 De$elopin) #u*to%er e"perti*e3 =3 I%pro$e%ent in US %arBet *'are o- t'e pro(u#t3
•.
T'reat* 7E"ternal8
:3 A%eri#an +a* -o#u*e( %ore on #o*%eti# rat'er t'an *u,*tanti$e3
IV5ASSUMPTION •
>in)er pre**ure a* a %ea*ure o- #entral ,loo( pre**ure/ ,ut +ere not *ure 'o+ #lo*el& 0n)er pre**ure *ti%ulate* #entral pre**ure o- 'o+ a##uratel& +ere %ea*urin) 0n)er pre**ure3
V5 ALTERNATIVE .OURSES O> A.TION 7 A.A 8 :3 Pro$i(e pro(u#t *e%inar per-or%e( ,& t'e per*on *pe#ialiFin) t'e pro(u#t3 Pro(u#e alternati$e ,loo( %onitorin) (e$i#e *uita,le -or people +it' (i#ult& in )ettin) t'e ,loo( pre**ure t&pe3
VI5 ANALYSIS >o#u* on t'e %arBetin) *trate)& an( an( 'ire people +it' te#'ni#al e"perti*e to -urt'er i%pro$e t'e pro(u#t3 I%pro$e #u rea(in) a* +ell to )et an a##urate re*ult3
VII5 .ON.LUSION 2e t'ere-ore #on#lu(e/ it i* i%portant to re#o)niFe t'at t'e Be& inuen#e -or pur#'a*e* i* an ane*t'e*iolo)i*t/ -or +'o% ,loo( pre**ure i* 9u*t one o- %an& #on#ern*3 In ot'er *e)%ent* o- t'e 'o*pital/ t'e *ituation i* $er& (ierent3 In t'e ..U/ or t'e #ar(ia# operatin) t'eater/ ,loo( pre**ure i* o- para%ount i%portan#e3 Not all pro#e(ure* are len)t'&/ an( e$en +'ere t'e& are/ %an& #ar(iolo)i*t *a+ $alue in .NI!P/ e$en t'ou)' t'ere +a* (ri-t3 >or p'&*iolo)i*t %ea*ure%ent in re*ear#' 'o*pital* or in '&perten*ion unit*/ t'ere +ere e$en -e+er (ra+,a#B*/ an( t'e #lini#ian* in t'e*e *ituation* +ere %u#' %ore in#line( to taBe e"tra #are +it' appli#ation o- t'e #u3
Joseph W. Pepper
3 days
4 days
Contineous
END
